![Jason Silvers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 26 240 $ al 31/05/2026
Jason Silvers is currently President & Chief Financial Officer at Generate Biomedicines, Inc., a position starting in 2026.
Formerly, Dr. Silvers was Managing Director at Goldman Sachs & Co. LLC from 2002 to 2022.
Education includes undergraduate studies at Brown University, a doctorate from The Johns Hopkins University School of Medicine, and graduate studies at Yale Law School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/03/2026 | 2.000 ( 0 % ) | 26 240 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENERATE BIOMEDICINES, INC. | Director Financiero/CFO | 01/07/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/06/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale Law School
 Yale Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
